Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.

Feuerlein S, Gupta RT, Boll DT, Merkle EM.

Eur J Radiol. 2012 Sep;81(9):2037-41. doi: 10.1016/j.ejrad.2011.06.014. Epub 2011 Jun 29.

PMID:
21719224
2.

Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.

Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.

Eur J Radiol. 2012 Oct;81(10):2457-62. doi: 10.1016/j.ejrad.2011.10.014. Epub 2011 Dec 3.

PMID:
22138122
3.

Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.

Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N.

Acta Radiol. 2009 Sep;50(7):709-15. doi: 10.1080/02841850903055603.

PMID:
19701821
4.

Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.

Nural MS, Gokce E, Danaci M, Bayrak IK, Diren HB.

Eur J Radiol. 2008 Apr;66(1):65-74. Epub 2007 Jun 6.

PMID:
17555901
5.

Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents--comparison of Gd-EOB-DTPA and Gd-BOPTA.

Ringe KI, Boll DT, Husarik DB, Bashir MR, Gupta RT, Merkle EM.

BMC Med Imaging. 2013 Mar 18;13:10. doi: 10.1186/1471-2342-13-10.

6.

Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.

Colosimo C, Demaerel P, Tortori-Donati P, Christophe C, Van Buchem M, Högström B, Pirovano G, Shen N, Kirchin MA, Spinazzi A.

Pediatr Radiol. 2005 May;35(5):501-10. Epub 2005 Jan 28.

PMID:
15678342
7.

Comparison of Dynamic Phase Enhancement of Hepatocellular Carcinoma Using Gadoxetate Disodium vs Gadobenate Dimeglumine.

Tirkes T, Mehta P, Aisen AM, Lall C, Akisik F.

J Comput Assist Tomogr. 2015 Jul-Aug;39(4):479-82. doi: 10.1097/RCT.0000000000000234.

PMID:
25783800
8.

Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA, and Gd-BOPTA for dynamic MR imaging of the liver in rat models.

Jaw TS, Chen SH, Wang YM, Hsu JS, Kuo YT, Chiu YY, Tsai KB, Hsieh TJ, Liu GC.

Kaohsiung J Med Sci. 2012 Mar;28(3):130-7. doi: 10.1016/j.kjms.2011.10.017. Epub 2012 Jan 20.

9.

A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.

Runge VM.

J Comput Assist Tomogr. 1998 Jul-Aug;22(4):643-50.

PMID:
9676461
10.
11.

Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.

Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.

Acta Radiol. 2007 May;48(4):362-8.

PMID:
17453513
12.

Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.

Yeom SK, Byun JH, Kim HJ, Park SH, Kim N, Shin YM, Kim PN.

Magn Reson Imaging. 2013 Jul;31(6):911-7. doi: 10.1016/j.mri.2013.02.002. Epub 2013 Apr 15.

PMID:
23598063
13.

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.

Filippone A, Blakeborough A, Breuer J, Grazioli L, Gschwend S, Hammerstingl R, Heinz-Peer G, Kittner T, Laghi A, Leen E, Lencioni R, Lucidarme O, Remplik P, Robinson PJ, Ruehm SG, Schaefer F, Stoupis C, Tombach B, Valette PJ, Zech CJ, Huppertz A.

J Magn Reson Imaging. 2010 Feb;31(2):356-64. doi: 10.1002/jmri.22054.

PMID:
20099349
14.

Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.

Kuwatsuru R, Kadoya M, Ohtomo K, Tanimoto A, Hirohashi S, Murakami T, Tanaka Y, Yoshikawa K, Katayama H.

Invest Radiol. 2001 Nov;36(11):632-41.

PMID:
11606840
15.

[Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].

Zhang HM, Ouyang H, Zhou CW.

Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):111-5. Chinese.

PMID:
16750014
16.

Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.

Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T.

J Magn Reson Imaging. 2009 Mar;29(3):636-40. doi: 10.1002/jmri.21689.

PMID:
19243060
17.

Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.

Fujinaga Y, Ohya A, Matsushita T, Kurozumi M, Ueda K, Kitou Y, Ueda H, Kadoya M.

Jpn J Radiol. 2011 Dec;29(10):695-700. doi: 10.1007/s11604-011-0615-5. Epub 2011 Oct 19.

PMID:
22009420
18.

Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.

Bauner KU, Reiser MF, Huber AM.

Invest Radiol. 2009 Feb;44(2):95-104. doi: 10.1097/RLI.0b013e3181911eab.

PMID:
19077911
19.
20.

Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.

Nassenstein K, Breuckmann F, Hunold P, Barkhausen J, Schlosser T.

Acta Radiol. 2009 May;50(4):406-11. doi: 10.1080/02841850902838066.

PMID:
19308763

Supplemental Content

Support Center